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L E T T E R TO TH E ED I TO R
A known pathogenic variant in the essential mitochondrial
translation gene RMND1 causes a Perrault-like syndrome with
renal defects
To the Editor:
Perrault syndrome is a rare autosomal recessive condition character-
ized by sensorineural hearing loss (SNHL) in both sexes and primary
ovarian insufficiency (POI) in 46, XX females. Additional phenotypes,
especially progressive neurological features affect some individuals.
Six genes have been identified as causative for Perrault syndrome:
HSD17B4, HARS2, LARS2, CLPP, C10orf2 and ERAL1, the latter 5 of
which function in mitochondrial translation.1,2 As many cases of Per-
rault syndrome are unresolved at a genetic level it is suggested that
additional Perrault genes are undiscovered.1
We present a case with the defining clinical features of Perrault
syndrome, in addition to renal dysfunction and short stature, associ-
ated with a known pathogenic variant, RMND1 c.713A>G p.(Asn238-
Ser).3 Patients provided written informed consent in accordance with
local regulations. Ethical approval was granted by the National Health
Service Ethics Committee (16/WA/0017) and the University of Man-
chester. The proband is from a non-consanguineous Portuguese fam-
ily with unaffected parents and 2 unaffected brothers. SNHL was
noted at 7 years of age and was moderate to severe at 16 years of
age. At 10 years of age short stature, growth hormone deficiency and
POI were observed. She also had distal renal tubular acidosis, renal
dysfunction has not been previously associated with Perrault syn-
drome. The proband had 2 measurements of lactic acid with ele-
vated/borderline results; postprandial: 2.01 mmol/L (reference: <1.8)
and 1.9 mmol/L (reference: 0.5-1.6). A full neurological evaluation,
including electromyography, was performed with no neurological
phenotype noted. The proband attends a mainstream school and
undertakes age appropriate work with no additional assistance. No
additional members of the family reported any health problems.
Whole exome sequencing was performed on the proband
(SureSelect Human All Exon V5 Panel [Agilent, Santa Clara, California]
and HiSeq 2500 [Illumina, San Diego, California]).1 No putative path-
ogenic variants were identified in known Perrault syndrome genes.
We classified the homozygous known pathogenic variant, RMND1
c.713A>G p.(Asn238Ser) (NM_017909) as the likely cause of the phe-
notype in the proband. The variant segregated with the phenotype
(Sanger sequencing using ABI big Dye v3.1 technology [ThermoFisher
Scientific Inc.]); both parents and both unaffected siblings were
heterozygous.
RMND1 has been proposed to tether the mitoribosome to the
mitochondrial inner matrix.4 Variants in RMND1 are associated with a
wide phenotypic range including SNHL, hypotonia, developmental
delay, lactic academia and renal dysfunction. Many patients have a
defect in mitochondrial translation.3
The variant RMND1 c.713A>G has been observed as homozy-
gous in 2 unrelated families (Table 1). In both families SNHL, develop-
mental delay, hypotonia and peripheral spasticity were observed, one
patient had renal dysfunction. All 3 affected individuals are pre-
pubertal, including 1 affected female.3 The phenotypic range associ-
ated with this RMND1 variant suggests modifying factors, which may
be components of the mitochondrial translation pathway.
POI has not been previously associated with variants in RMND1.
In most reported cases of RMND1-related disorders, patients have
been of pre-pubertal age so POI may not have yet become apparent.3
In 2 affected sisters, aged 17 and 14 years, with the RMND1
c.713A>G variant compound heterozygous with another variant, the
absence or presence of POI was not commented upon.3,5 This may
indicate that POI is not a feature of all cases of RMND1-associated
mitochondrial dysfunction.
We suggest that patients with Perrault syndrome are screened
for variants in RMND1 alongside the known Perrault syndrome genes.
Renal phenotypes in women with Perrault syndrome features may
indicate the causative variant is in RMND1 but the absence of renal
dysfunction should not preclude RMND1 screening. We also suggest
that POI may be an unrecognized feature of RMND1-related mito-
chondrial dysfunction and female patients should be monitored
for POI.
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TABLE 1 Clinical features of individuals homozygous for the variant RMND1 c.713A>G p.(Asn238Ser)
Individual ID 4.1 4.2 5 II-1
Reference 3 This report
Ethnicity Caucasian Caucasian Caucasian, Native American Caucasian (Portuguese)
Consanguinity N N N N
Sex M M F F
Onset (y) 0.5 Birth Birth 7
Age (y) at last
assessment
8 6 9 16
SNHL Bilateral SNHL Bilateral SNHL Congenital bilateral
progressive SNHL, mid to
high frequencies
Bilateral progressive moderate/severe SNHL
Gonadal
dysfunction
NR NR NR Ovarian atrophy and hypergonadotropic
hypogonadism
Renal
dysfunction
N N Cystic dysplasia, possible renal
tubular acidosis, end stage
renal failure, renal
transplant
Distal renal tubular acidosis with
hyperchloremic metabolic acidosis and a
normal anion gap, uric acid mildly elevated,
low urine citrate levels, normal calcium
levels and a normal renal ultrasound
Developmental
delay
Y Yes with regression
at 4 y
Yes with failure to thrive N
Neurological
features
Y Y Y N
Tone Central hypotonia and
peripheral spasticity
Central hypotonia
and peripheral
spasticity
Central hypotonia and
peripheral spasticity
Normal
Epilepsy Febrile seizures Febrile seizures Y N
MRI Leukoencephalopathy
temporal lobe cyst
NR Cerebral atrophy and white
matter changes
Normal (spectroscopy not performed)
Additional
features
NR Torticollis and
plagiocephaly
Microcephaly, hypertension,
mild ventricular
hypertrophy
Growth hormone deficiency, autoimmune
thrombocytopenia, non-immune
hypothyroidism, femoral epiphysiolysis
(13 y of age), ECG normal
Abbreviations: ECG, electrocardiogram; F, female; M, male; MRI, magnetic resonance imaging; N, no; NR, not recorded; SNHL, sensorineural hearing
loss; Y, yes.
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